Tucson、AZにおける転移性癌の臨床試験
Tucsonとその周辺地域(約30マイル以内)の拠点で、転移性癌に関する14件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト(英語)
ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
被験者募集中第1相
- University of Arizona Cancer Center, Tucson
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
被験者募集中第2/3相
- The University of Arizona Cancer Center, Tucson
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
被験者募集中第2相
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
被験者募集中第3相
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- The University of Arizona Cancer Center - North Campus, Tucson
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
被験者募集中第3相
- The University of Arizona Cancer Center - North Campus, Tucson
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
被験者募集中第3相
- University of Arizona-Cancer Center, Tucson
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
被験者募集中第1相
- University of Arizona - Cancer Center, Tucson
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Arizona Cancer Center at University of Arizona, Tucson
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
被験者募集中第3相
- Research Site, Tucson
Symptom Management and Survivorship Plus Coaching for Advanced Cancer Survivors and Their Caregivers
被験者募集中
- University of Arizona Cancer Center, Tucson
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
被験者募集中第3相
- The University of Arizona Cancer Center, Tucson
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- The University of Arizona Cancer Center, Tucson
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
被験者募集中第1相
- University of Arizona, Tucson
他の都市における転移性癌の試験
- Houston, TX104件の研究
- New York City, NY93件の研究
- Nashville, TN70件の研究
- Boston, MA63件の研究
- Los Angeles, CA57件の研究
- St. Louis, MO54件の研究
- Arlington, VA53件の研究
- Philadelphia, PA46件の研究
- Chicago, IL45件の研究
- San Antonio, TX44件の研究
- Washington, DC43件の研究
- Dallas, TX42件の研究
Tucsonにおける他の研究
- 乳がん20件の研究
- 肥満症18件の研究
- 非小細胞肺癌17件の研究
- 過体重15件の研究
- がん(全種類)12件の研究
- 心血管疾患12件の研究
- 大腸癌11件の研究
- 前立腺がん11件の研究
- 2型糖尿病11件の研究
- 脂肪肝10件の研究
- 心不全10件の研究
- 高血圧10件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。